Fusogenic compounds for delivery of biologically active molecules
US-12440445-B2 · Oct 14, 2025 · US
This page is not indexed by search engines while we improve data quality.
Adami Roger patents
Adami Roger is listed as an inventor on 32 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Adami Roger |
| Total patents | 32 |
| First publication | Jun 30, 2016 |
| Latest publication | Oct 14, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Ionizable compounds and compositions and uses thereof
US-2025250226-A1 · Aug 7, 2025 · US
Ionizable compounds and compositions and uses thereof
US-12319643-B2 · Jun 3, 2025 · US
Compositions and methods for nanoparticle lyophile forms
US-12311055-B2 · May 27, 2025 · US
Compositions and methods for nanoparticle lyophile forms
US-2024000710-A1 · Jan 4, 2024 · US
Compositions and methods for nanoparticle lyophile forms
US-11737982-B2 · Aug 29, 2023 · US
Methods and compositions for treating malignant tumors associated with KRAS mutation
US-RE49229-E · Oct 4, 2022 · US
Methods and compositions for treating malignant tumors associated with kras mutation
US-2022275373-A1 · Sep 1, 2022 · US
Fusogenic compounds for delivery of biologically active molecules
US-11413243-B2 · Aug 16, 2022 · US
Ionizable compounds and compositions and uses thereof
US-2022242820-A1 · Aug 4, 2022 · US
Recent patents
Latest publications not already listed above.
Fusogenic compounds for delivery of biologically active molecules
US-2022233445-A1 · Jul 28, 2022 · US
Ionizable compounds and compositions and uses thereof
US-11384051-B2 · Jul 12, 2022 · US
Methods and compositions for treating malignant tumors associated with KRAS mutation
US-11352628-B2 · Jun 7, 2022 · US
Rna interference compositions and methods for malignant tumors
US-2022087531-A1 · Mar 24, 2022 · US
dsRNA Directed to Coronavirus Proteins
US-2022049251-A1 · Feb 17, 2022 · US
RNA interference compositions and methods for malignant tumors
US-RE48887-E · Jan 11, 2022 · US
Methods and compositions for treating malignant tumors associated with kras mutation
US-10792299-B2 · Oct 6, 2020 · US
Methods and compositions for treating malignant tumors associated with kras mutation
US-2019367926-A1 · Dec 5, 2019 · US
Compositions and methods for nanoparticle lyophile forms
US-2019231695-A1 · Aug 1, 2019 · US
Compositions and methods for nanoparticle lyophile forms
US-10300018-B2 · May 28, 2019 · US
Fusogenic compounds for delivery of biologically active molecules
US-2019133948-A1 · May 9, 2019 · US
Ionizable compounds and compositions and uses thereof
US-2019127318-A1 · May 2, 2019 · US
Ionizable compounds and compositions and uses thereof
US-10167253-B2 · Jan 1, 2019 · US
Rna interference therapeutics against ebola virus
US-2018235995-A1 · Aug 23, 2018 · US
Methods and compositions for treating malignant tumors associated with kras mutation
US-2018002702-A1 · Jan 4, 2018 · US
RNA interference compositions and methods for malignant tumors
US-9771582-B2 · Sep 26, 2017 · US
Methods and compositions for treating malignant tumors associated with kras mutation
US-2017165289-A1 · Jun 15, 2017 · US
Methods and compositions for treating malignant tumors associated with KRAS mutation
US-9580710-B2 · Feb 28, 2017 · US
Compositions and methods for nanoparticle lyophile forms
US-2017020819-A1 · Jan 26, 2017 · US
Ionizable compounds and compositions and uses thereof
US-2016376229-A1 · Dec 29, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Nitto Denko Corp | 32 |
| Ying Wenbin | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/713 | 27 |
| A61K31/7105 | 24 |
| C12N2310/14 | 21 |
| C12N15/113 | 20 |
| A61K9/127 | 18 |